Cargando…

TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes

BACKGROUND: Variants in the TCF7L2 have been shown to be associated with an increased risk for type 2 diabetes (T2D). Since the association with diabetes could be explained by effects on insulin secretion, we investigated whether patients with diabetes risk alleles at rs7903146 might have an altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holstein, Andreas, Hahn, Michael, Körner, Antje, Stumvoll, Michael, Kovacs, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051886/ https://www.ncbi.nlm.nih.gov/pubmed/21349175 http://dx.doi.org/10.1186/1471-2350-12-30

Ejemplares similares

KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment
por: Song, Jingwen, et al.
Publicado: (2017)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

The TCF7L2 locus and type 1 diabetes
por: Qu, Hui-Qi, et al.
Publicado: (2007)

TCF7L2 Variation and Proliferative Diabetic Retinopathy
por: Luo, Jing, et al.
Publicado: (2013)

Functional analysis of TCF7L2 genetic variants associated with type 2 diabetes
por: Pang, D.X., et al.
Publicado: (2013)

Sulfonylurea: Personalized Medicine for Type 2 Diabetes
por: Hwang, You-Cheol
Publicado: (2015)

The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes
por: Grant, Struan F.A.
Publicado: (2019)

Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population
por: Alsmadi, Osama, et al.
Publicado: (2008)

Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population
por: Amoli, Mahsa M., et al.
Publicado: (2010)

Effect of TCF7L2 polymorphism on pancreatic hormones after exenatide in type 2 diabetes
por: Ferreira, Mari Cassol, et al.
Publicado: (2019)

TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes
por: Ganmore, Ithamar, et al.
Publicado: (2019)

The broad pathogenetic role of TCF7L2 in human diseases beyond type 2 diabetes
por: del Bosque‐Plata, Laura, et al.
Publicado: (2021)

Habenular Tcf7l2 links nicotine addiction to diabetes
por: Duncan, Alexander, et al.
Publicado: (2019)

TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes
por: Redondo, Maria J., et al.
Publicado: (2018)

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes
por: Hanefeld, M
Publicado: (2007)

Association of TCF7L2 variation with single islet autoantibody expression in children with type 1 diabetes
por: Redondo, Maria J, et al.
Publicado: (2014)

Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus – International Task Force
por: Kalra, Sanjay, et al.
Publicado: (2018)

Tissue-specific alternative splicing of TCF7L2
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009)

Type 2 Diabetes Susceptibility Gene TCF7L2 and Its Role in β-Cell Function
por: Gloyn, Anna L., et al.
Publicado: (2009)

Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
por: Hindy, G., et al.
Publicado: (2012)

Association of the rs11196218 polymorphism in TCF7L2 with type 2 diabetes mellitus in Asian population
por: Zhai, Yujia, et al.
Publicado: (2014)

Association of TCF7L2 Genetic Polymorphisms with Type 2 Diabetes Mellitus in the Uygur Population of China
por: Yao, Hua, et al.
Publicado: (2015)

No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
por: Mathiesen, David S, et al.
Publicado: (2020)

TCF7L2: the biggest story in diabetes genetics since HLA?
por: Zeggini, E., et al.
Publicado: (2006)

Reduction in Tcf7l2 Expression Decreases Diabetic Susceptibility in Mice
por: Yang, Hyekyung, et al.
Publicado: (2012)

Tcf7l2/Tcf4 Transcriptional Repressor Function Requires HDAC Activity in the Developing Vertebrate CNS
por: Wang, Hui, et al.
Publicado: (2016)

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin
por: Zimdahl, Heike, et al.
Publicado: (2014)

Commentary on “Consensus Recommendations on Sulfonylurea and Sulfonylurea Combinations in the Management of Type 2 Diabetes Mellitus: International Task Force”
por: Singh, S. K.
Publicado: (2018)

Effects of the diabetes linked TCF7L2 polymorphism in a representative older population
por: Melzer, David, et al.
Publicado: (2006)

Clinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes
por: Min, Se Hee, et al.
Publicado: (2015)

Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2009)

Association of the TCF7L2 rs12255372 (G/T) variant with type 2 diabetes mellitus in an Iranian population
por: Alami, Faranak Mahmoudi, et al.
Publicado: (2012)

TCF7L2 Variant rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action
por: Villareal, Dennis T., et al.
Publicado: (2010)

Association of rs12255372 in the TCF7L2 gene with type 2 diabetes mellitus: a meta-analysis
por: Wang, Jinjin, et al.
Publicado: (2013)

The TCF7L2 rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population
por: Ouhaibi-Djellouli, Hadjira, et al.
Publicado: (2014)

Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus
por: Ding, Weiyue, et al.
Publicado: (2018)

Common variants in TCF7L2 and CDKAL1 genes and risk of type 2 diabetes mellitus in Egyptians
por: El-Lebedy, Dalia, et al.
Publicado: (2016)

Publisher Correction: TCF7L2 polymorphisms are associated with amygdalar volume in elderly individuals with Type 2 Diabetes
por: Ganmore, Ithamar, et al.
Publicado: (2020)

Association of TCF7L2 Variants in Type 2 Diabetes Mellitus with Hypertriglyceridemia – A Case-Control Study
por: Gunavathy, Nagarajan, et al.
Publicado: (2023)

Transcription Factor-7-Like-2 (TCF7L2) in Atherosclerosis: A Potential Biomarker and Therapeutic Target
por: Li, Junyi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_la6k4gf58o16iv37qtsqnbu6v1